The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.
The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.
Study Type
OBSERVATIONAL
Enrollment
8
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Overall Survival (OS)
OS is defined as the length of time from study enrollment to death by any cause. Survival status of patients will be monitored every 6 months
Time frame: 2 years
Progression free survival (PFS) as evidenced by CT scan review
PFS is defined as the length of time from study enrollment to the time of disease progression.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.